.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Medtronic
Harvard Business School
Dow
Moodys
Merck
Johnson and Johnson
Mallinckrodt
Accenture
Farmers Insurance

Generated: September 22, 2017

DrugPatentWatch Database Preview

Metaraminol bitartrate - Generic Drug Details

« Back to Dashboard

What are the generic sources for metaraminol bitartrate and what is the scope of metaraminol bitartrate patent protection?

Metaraminol bitartrate
is the generic ingredient in two branded drugs marketed by Merck, Gd Searle Llc, Fresenius Kabi Usa, Abraxis Pharm, and Elkins Sinn, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

Summary for Generic Name: metaraminol bitartrate

Tradenames:2
Patents:0
Applicants:5
NDAs:5
Bulk Api Vendors: see list31
Clinical Trials: see list48
Patent Applications: see list491
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:metaraminol bitartrate at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Elkins Sinn
METARAMINOL BITARTRATE
metaraminol bitartrate
INJECTABLE;INJECTION083363-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Merck
ARAMINE
metaraminol bitartrate
INJECTABLE;INJECTION009509-002Dec 22, 1987DISCNYesNo► Subscribe► Subscribe► Subscribe
Gd Searle Llc
METARAMINOL BITARTRATE
metaraminol bitartrate
INJECTABLE;INJECTION086418-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Gd Searle Llc
METARAMINOL BITARTRATE
metaraminol bitartrate
INJECTABLE;INJECTION086418-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Fresenius Kabi Usa
METARAMINOL BITARTRATE
metaraminol bitartrate
INJECTABLE;INJECTION080722-001Approved Prior to Jan 1, 1982RXNoYes► Subscribe► Subscribe► Subscribe
Abraxis Pharm
METARAMINOL BITARTRATE
metaraminol bitartrate
INJECTABLE;INJECTION080431-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Novartis
Express Scripts
Teva
Harvard Business School
Baxter
Chinese Patent Office
Daiichi Sankyo
Fish and Richardson
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot